Becton, Dickinson (BDX) Enters Patent Settlement with Gen-Probe
Tweet Send to a FriendGet Alerts BDX Hot Sheet
Price: $100.40 +0.23%
Overall Analyst Rating:
NEUTRAL (
Up)
Dividend Yield: 2%
Revenue Growth %: +0.5%
Overall Analyst Rating:
NEUTRAL (
Up)Dividend Yield: 2%
Revenue Growth %: +0.5%
Trade BDX Now!
On December 1, 2012, Becton, Dickinson and Company (NYSE: BDX) signed a definitive settlement agreement with Gen-Probe in the action before the U.S. District Court for the Southern District of California. Under the settlement, BD is granted a license to make, use and sell products accused of infringing Gen-Probe patents in the action.
The payments that BD will make to Gen-Probe under the settlement, which include an upfront payment and ongoing royalties, are not material to BD, and the parties have requested that the Court dismiss the action.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The payments that BD will make to Gen-Probe under the settlement, which include an upfront payment and ongoing royalties, are not material to BD, and the parties have requested that the Court dismiss the action.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Ackman's Pershing Square Says Herbalife (HLF) Refuses to Release Sales Data, Calls for Probe
- SAM Encourages Spectra (SE) to Unlock More Value; Sees Intrinsic Price of $48
- Chevron (CVX) to Sell Interest in 3 Additional Nigerian Oil Leases
Create E-mail Alert Related Categories
Corporate News, Litigation
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
